In terms of blocking tumor-promoting signals and repolarization of TAMs, inhibition of the CSF-1R has been shown to preferentially eliminate macrophages with an inflammatory signature but spare macrophage populations expressing proangiogenic/cancer genes in mice and humans [82]. The gene discussed is CSF1R; the disease is neoplasm.